370 related articles for article (PubMed ID: 31226232)
1. Metabolically healthy versus unhealthy obesity and risk of fibrosis progression in non-alcoholic fatty liver disease.
Kim Y; Chang Y; Cho YK; Ahn J; Shin H; Ryu S
Liver Int; 2019 Oct; 39(10):1884-1894. PubMed ID: 31226232
[TBL] [Abstract][Full Text] [Related]
2. Metabolically healthy and unhealthy obesity and the progression of liver fibrosis: A cross-sectional study.
Tutunchi H; Naeini F; Ebrahimi-Mameghani M; Najafipour F; Mobasseri M; Ostadrahimi A
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101754. PubMed ID: 34303827
[TBL] [Abstract][Full Text] [Related]
3. Association between metabolically healthy obesity and non-alcoholic fatty liver disease.
Man S; Lv J; Yu C; Deng Y; Yin J; Wang B; Li L; Liu H
Hepatol Int; 2022 Dec; 16(6):1412-1423. PubMed ID: 35987840
[TBL] [Abstract][Full Text] [Related]
4. Obesity and Weight Gain Are Associated With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Kim Y; Chang Y; Cho YK; Ahn J; Shin H; Ryu S
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):543-550.e2. PubMed ID: 30012432
[TBL] [Abstract][Full Text] [Related]
5. Metabolically healthy obesity is associated with an increased risk of diabetes independently of nonalcoholic fatty liver disease.
Chang Y; Jung HS; Yun KE; Cho J; Ahn J; Chung EC; Shin H; Ryu S
Obesity (Silver Spring); 2016 Sep; 24(9):1996-2003. PubMed ID: 27474900
[TBL] [Abstract][Full Text] [Related]
6. Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status.
Huh JH; Kim KJ; Kim SU; Han SH; Han KH; Cha BS; Chung CH; Lee BW
Metabolism; 2017 Jan; 66():23-31. PubMed ID: 27923446
[TBL] [Abstract][Full Text] [Related]
7. Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease.
Chang Y; Jung HS; Cho J; Zhang Y; Yun KE; Lazo M; Pastor-Barriuso R; Ahn J; Kim CW; Rampal S; Cainzos-Achirica M; Zhao D; Chung EC; Shin H; Guallar E; Ryu S
Am J Gastroenterol; 2016 Aug; 111(8):1133-40. PubMed ID: 27185080
[TBL] [Abstract][Full Text] [Related]
8. Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study.
Chang Y; Cho YK; Kim Y; Sung E; Ahn J; Jung HS; Yun KE; Shin H; Ryu S
Hepatology; 2019 Jan; 69(1):64-75. PubMed ID: 30019340
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.
Golabi P; Paik JM; Kumar A; Al Shabeeb R; Eberly KE; Cusi K; GunduRao N; Younossi ZM
Metabolism; 2023 Sep; 146():155642. PubMed ID: 37380016
[TBL] [Abstract][Full Text] [Related]
10. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?
Machado MV; Policarpo S; Coutinho J; Carvalhana S; Leitão J; Carvalho A; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Cortez-Pinto H
Obes Surg; 2020 Feb; 30(2):560-568. PubMed ID: 31637670
[TBL] [Abstract][Full Text] [Related]
11. Metabolically healthy and unhealthy obesity phenotypes and risk of renal stone: a cohort study.
Kim S; Chang Y; Yun KE; Jung HS; Kim I; Hyun YY; Lee KB; Joo KJ; Park HJ; Shin H; Ryu S
Int J Obes (Lond); 2019 Apr; 43(4):852-861. PubMed ID: 30006578
[TBL] [Abstract][Full Text] [Related]
12. Patients with clinically metabolically healthy obesity are not necessarily healthy subclinically: further support for bariatric surgery in patients without metabolic disease?
Haskins IN; Chang J; Nor Hanipah Z; Singh T; Mehta N; McCullough AJ; Brethauer SA; Schauer PR; Aminian A
Surg Obes Relat Dis; 2018 Mar; 14(3):342-346. PubMed ID: 29519663
[TBL] [Abstract][Full Text] [Related]
13. High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China.
Yu X; Chen C; Guo Y; Tong Y; Zhao Y; Wu L; Sun X; Wu X; Song Z
Ann Med; 2021 Dec; 53(1):1621-1631. PubMed ID: 34498502
[TBL] [Abstract][Full Text] [Related]
14. A Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Murphy N; Cross AJ; Abubakar M; Jenab M; Aleksandrova K; Boutron-Ruault MC; Dossus L; Racine A; Kühn T; Katzke VA; Tjønneland A; Petersen KE; Overvad K; Quirós JR; Jakszyn P; Molina-Montes E; Dorronsoro M; Huerta JM; Barricarte A; Khaw KT; Wareham N; Travis RC; Trichopoulou A; Lagiou P; Trichopoulos D; Masala G; Krogh V; Tumino R; Vineis P; Panico S; Bueno-de-Mesquita HB; Siersema PD; Peeters PH; Ohlsson B; Ericson U; Palmqvist R; Nyström H; Weiderpass E; Skeie G; Freisling H; Kong SY; Tsilidis K; Muller DC; Riboli E; Gunter MJ
PLoS Med; 2016 Apr; 13(4):e1001988. PubMed ID: 27046222
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity.
Lonardo A; Mantovani A; Lugari S; Targher G
Ann Hepatol; 2020; 19(4):359-366. PubMed ID: 32349939
[TBL] [Abstract][Full Text] [Related]
16. Association Between Nonalcoholic Fatty Liver Disease and Future Deterioration of Metabolic Health: A Cohort Study.
Hwang YC; Ahn HY; Park CY
Obesity (Silver Spring); 2019 Aug; 27(8):1360-1366. PubMed ID: 31245932
[TBL] [Abstract][Full Text] [Related]
17. Abdominal obesity phenotypes are associated with the risk of developing non-alcoholic fatty liver disease: insights from the general population.
Kuang M; Lu S; Xie Q; Peng N; He S; Yu C; Qiu J; Sheng G; Zou Y
BMC Gastroenterol; 2022 Jun; 22(1):311. PubMed ID: 35752753
[TBL] [Abstract][Full Text] [Related]
18. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
19. Association between non-alcoholic fatty liver disease and metabolically healthy deterioration across different body shape phenotypes at baseline and change patterns.
Lei L; Changfa W; Jiangang W; Zhiheng C; Ting Y; Xiaoling Z; Yuling D; Yaqin W
Sci Rep; 2022 Aug; 12(1):14786. PubMed ID: 36042236
[TBL] [Abstract][Full Text] [Related]
20. Baseline homeostasis model assessment of insulin resistance associated with fibrosis progression in patients with nonalcoholic fatty liver disease without diabetes: A cohort study.
Koo DJ; Lee MY; Jung I; Moon SJ; Kwon H; Park SE; Rhee EJ; Lee WY
PLoS One; 2021; 16(8):e0255535. PubMed ID: 34432804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
